-
-
-
-
-
-
-
Amgen And Kyowa Kirin Present Positive Late-Breaking Data From Phase 2 Study Of AMG 451/KHK4083 In Adult Patients With Moderate-to-Severe Atopic Dermatitis At EADV Congress
-
-
-
-
-
-
923,168 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All